Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 41Other hematologic neoplasm 27Gastrointestinal 27Thoracic 20Plasma cell 14Gynecologic 13Myeloid 12Sarcoma 11Head & Neck 11Genitourinary 11CNS 11Dermatologic 8Endocrine 7Other neoplasm 5NET 5Breast 4Tumor-Agnostic 2Other solid neoplasm 1

Conditions

Neoplasms 2798Neoplasm Metastasis 676Adenocarcinoma 99Carcinoma 97Carcinoma, Squamous Cell 75Neoplasms, Unknown Primary 29Neoplasm, Residual 15Neoplasms, Second Primary 14Neoplasms by Site 4Neoplasms by Histologic Type 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms by Histologic Type × Tumor-Agnostic × Clear all
NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Phase 1 Unknown
189 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms by Histologic Type

NCT03109639 2020-03-19

A Randomized Prospective Comparison of the New EUS Guided Acquire TM Needle Biopsy vs EUS Guided Fine Needle Aspiration for Suspected Solid Gastrointestinal Lesions

Singapore General Hospital

Phase NA Completed
36 enrolled
Tumor-Agnostic

Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡